Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
10/2003
10/09/2003US20030191160 Aids therapy; calibration efficiency of benzimidazole compound
10/09/2003US20030191127 Process for preparing substituted benzimidazole compounds
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2479928A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003CN1447813A Late transition metal complexes, their use as catalysts and polymers therefrom
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447691A Pharmaceutical combination of angiotensin Ôàí antagonists and ace inhibitors
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630451 Benzimidazolone peptidometics as thrombin receptor antagonist
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003US20030187302 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1H-naphthalene-2 -one oxime
10/02/2003US20030187258 Bactericides
10/02/2003US20030187045 Central nervous system disorders; controlling lipid metabolism; respiratory system disorders
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1122442C Fungicidal mixtures
09/2003
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077855A2 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003CA2478534A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176438 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2)
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/18/2003US20030176329 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP0588858B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
09/17/2003CN1121209C Cosmetic compositions for photoprotection of skin and/or hair, based on synergistic mixture of screening agents, and uses thereof
09/12/2003WO2003073979A2 Derivatives of azaspiro compounds for the treatment of pain
09/11/2003US20030171591 Process for producing optically active sulfoxide derivative
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1342717A1 Benzimidazole derivatives
09/10/2003EP1341774A1 Fused heteroaromatic glucokinase activators
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341768A1 Therapeutic benzimidazole compounds
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072099A1 Peroxisome proliferator activated receptor modulators
09/04/2003US20030166929 Heterocyclic compounds useful as inhibitors of tyrosine kinases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166638 Technical field
09/04/2003US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
09/04/2003US20030165715 1 to 2 imidazole functional groups introduced into 2- or 2,6-sites of 9,10-substituted anthracene; organic efficiency, thermal stability, operationally stability; maintains driving voltage
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1339697A1 Method for producing a phenylene-bis-benzimidazole-tetrasulfonic acid disodium salt
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339400A1 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
09/03/2003CN1440391A Propane-1,3-dione derivatives
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
08/27/2003EP0920314B1 Non-peptide g-csf mimetics
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610721 Imidazo heterocyclic compounds
08/26/2003US6610323 An enteric coated pharmaceutical dosage form comprising an H+,K+- ATPase inhibitor is disclosed. The dosage form comprises at least two portions of the H+,K+- ATPase inhibitor to be released in at least two consecutive pulses.
08/26/2003CA2092211C Imidazole compounds, their preparation and use
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068774A1 Tricyclic n-acyl compounds
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068756A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders
08/21/2003CA2475825A1 Tricyclic n-acyl compounds
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 154